ABSTRACT Pulmonary mechanical function and gas exchange were studied in 33 The availability of human heart-lung transplantation at our institution has led to the referral of a large number of patients with advanced pulmonary hypertension for consideration of surgery. So far 33 patients suffering from primary pulmonary hypertension or pulmonary hypertension secondary to congenital heart disease with Eisenmenger physiology have been studied in our pulmonary function laboratory (data from nine of them have been reported' but are included here and expanded to provide a more complete evaluation). Previous reports of similar patients have been limited to single case studies or small groups and have shown disparate results'-6; isolated reports of a restrictive ventilatory defect3 and patients with airflow obstruction2 have appeared.
The availability of human heart-lung transplantation at our institution has led to the referral of a large number of patients with advanced pulmonary hypertension for consideration of surgery. So far 33 patients suffering from primary pulmonary hypertension or pulmonary hypertension secondary to congenital heart disease with Eisenmenger physiology have been studied in our pulmonary function laboratory (data from nine of them have been reported' but are included here and expanded to provide a more complete evaluation). Previous reports of similar patients have been limited to single case studies or small groups and have shown disparate results'-6; isolated reports of a restrictive ventilatory defect3 and patients with airflow obstruction2 have appeared.
Given this background, a larger series such as this one, in which patients were comprehensively studied in the same laboratory with a uniform protocol, should provide a more accurate assessment of lung function in patients with pulmonary hypertension.
Methods
Thirty three patients suffering from advanced (stage IV, New York Heart Association) pulmonary vascular disease resulting from primary pulmonary hypertension (18 cases) and from congenital heart disease with Eisenmenger physiology (15 cases) were considered suitable for heart-lung transplantation after examination by at least two independent physicians who agreed that life expectancy in each case was probably less than 12 months. Cardiac catheterisation and pulmonary angiography were performed before referral in all cases. These were not repeated here in view of the associated morbidity and mortality. All clinical data, however, were reviewed in detail and patients with known causes of pulmonary hypertension other than congenital heart disease were excluded.
Ages ranged from 17 to 45 with a mean of 32 years, and there were 17 men and 16 women. Almost half of the patients were smokers, with a mean smoking history of 18 pack years. No patient had a history of asthma, and blood eosinophil counts were consistently within normal limits. fifth of patients had a ratio more than I SD below the predicted value. The mean sGaw for the group was in the low normal range, but 75% and 45% had values more than 1 and 2 SDs respectively below the predicted value. 3 The mean TLCO for the entire population was 78% of predicted, and 70% of the patients had values more Since dyspnoea is a common presenting symptom in pulmonary hypertension, the finding of abnormal pulmonary mechanics may suggest a primary diagnosis of intrinsic lung disease. In our group, however, the severe dyspnoea and the considerable hypoxaemia were clearly disproportionate to the degree of derangement of pulmonary mechanical function. The failure to find a correlation between smoking history and lung function is at first sight surprising. This finding may be explained by the fact that only a minority of smokers develop airflow limitation demonstrable by the techniques used here. In addition, all of our patients had ceased smoking at least three years before the study. Undue emphasis should not be placed on the absence of any correlation between PAP and pulmonary functional indices in this group in view of the long interval (mean 10 months) between cardiac catheterisation and lung function tests.
Despite the severe hypoxaemia, TLCO was relatively well preserved (mean 78% predicted). This finding is in keeping with previous reports of patients with pulmonary hypertension secondary to pulmonary vascular disease, and contrasts with the severe impairment of diffusion capacity seen in patients with pulmonary hypertension resulting from parenchymal lung disease.' 5 Arterial hypoxaemia was almost invariably present (mean Pao2 58 mm Hg (7-7 kPa)) and Pao2 was greater than 80 mm Hg (107 kPa) in only 13% of cases. Right to left intracardiac shunting is the obvious explanation for hypoxaemia in the group with Eisenmenger physiology. Potential mechanisms to explain arterial hypoxaemia in patients with primary pulmonary hypertension include shunting through a patent foramen ovale, ventilation/perfusion (VA/4C) inequalities, and reductions in mixed venous Po2 as a result of a low cardiac output,15 which would further enhance the effects of VA/OC mismatching on gas exchange.
Our population included 18 patients with primary pulmonary hypertension and 15 with Eisenmenger physiology. The latter group included patients with a wide variety of congenital heart lesions whose only common feature was the presence of Eisenmenger physiology. Since the small numbers of patients precluded any meaningful comparison of individual heart lesions, we simply compared those with primary pulmonary hypertension and with Eisenmenger physiology. Not surprisingly, in view of their anatomical shunts, the latter group had a significantly lower mean Pao2. In addition, mean FEF25 -7s was significantly lower (p < 005) in the group with Eisenmenger physiology.
The precise pathogenetic mechanism responsible for altered pulmonary function described in this and other reports of patients with pulmonary hypertension is not clear. Changes in lung compliance have however been reported both in patients and animal models with altered pulmonary haemodynamics23 16 17 presumably resulting from mechanical coupling of the vascular and air spaces. Although we did not measure pressure volume relationships in our patients, the observed functional derangement might result from a similar mechanism. Alternatively, it has been postulated that patients such as these may develop mechanical alterations as a result of ischaemic lung disease, but data to support this hypothesis are not currently available.'8 Although low grade bronchitis and bronchiolitis have been described in patients with primary pulmonary hypertension who had evidence of airflow limitation, the basis for these changes is not clear, and they do not appear to be due to an increased incidence of respiratory tract infections.2
In conclusion, advanced pulmonary vascular disease resulting from primary pulmonary hypertension and from Eisenmenger physiology appears to be associated with appreciable disturbance of pulmonary function. Most of our patients had evidence of airway obstruction, and mean TLC was only 81 5% of predicted. Hypoxaemia was almost invariably present and disproportionate to the relatively minor mechanical abnormalities. Alveolar hyperventilation was seen in all cases. Patients with Eisenmenger physiology had greater mean PAP and lower values of Pao2 and FEF25 -75 than those with primary pulmonary hypertension, despite similar levels of disability. Further insight into pathophysiological mechanisms responsible for these functional changes could best be gained by detailed analysis of pressure-volume relationships and morphometric studies. Whatever mechanisms are operative, our data confirm that obstructive and restrictive ventilatory defects are common in patients with pulmonary vascular disease.
